Ubs Group Ag Mckesson Corp Call Options Transaction History

Ubs Group Ag

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 13, 2024	BUY	$473.42 - $539.26 $36.9 Million - $42.1 Million	78,000 New	78,000 $41.9 Million
Q3 2022 Nov 10, 2022	SELL	$321.25 - $373.84 $41.1 Million - $47.8 Million	-127,900 Reduced 66.3%	65,000 $22.1 Million
Q2 2022 Aug 10, 2022	SELL	$300.57 - $336.42 $2.13 Million - $2.39 Million	-7,100 Reduced 3.55%	192,900 $62.9 Million
Q1 2022 May 16, 2022	BUY	$244.61 - $310.48 $48.4 Million - $61.4 Million	197,800 Added 8990.91%	200,000 $61.2 Million
Q3 2020 Nov 12, 2020	BUY	$140.89 - $159.9 $28,177 - $31,980	200 Added 10.0%	2,200 $328,000

Q1 2020 May 01, 2020	SELL	$115.75 - $170.96 $1.04 Million - $1.54 Million	-9,000 Reduced 81.82%	2,000 $271,000
Q4 2019 Feb 14, 2020	BUY	$130.23 - $153.27 $1.43 Million - $1.69 Million	11,000 New	11,000 $1.52 Million

1,678

109M

676K

678K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $84.5B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.